bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Table from Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma
Authors: Philip Philip A. , Azar Ibrahim , Xiu Joanne , Hall Michael J. , Hendifar Andrew Eugene , Lou Emil , Hwang Jimmy J. , Gong Jun , Feldman Rebecca , Ellis Michelle , Stafford Phil , Spetzler David , Khushman Moh'd M. , Sohal Davendra , Lockhart A. Craig , Weinberg Benjamin A. , El-Deiry Wafik S. , Marshall John , Shields Anthony F. , Korn W. Michael
Published: April 2023

Supplementary Table from Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma
Supplementary Figure from Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma
Authors: Philip Philip A. , Azar Ibrahim , Xiu Joanne , Hall Michael J. , Hendifar Andrew Eugene , Lou Emil , Hwang Jimmy J. , Gong Jun , Feldman Rebecca , Ellis Michelle , Stafford Phil , Spetzler David , Khushman Moh'd M. , Sohal Davendra , Lockhart A. Craig , Weinberg Benjamin A. , El-Deiry Wafik S. , Marshall John , Shields Anthony F. , Korn W. Michael
Published: April 2023

Supplementary Figure from Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma
Supplementary Figure from First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy
Authors: Diamond Jennifer R. , Boni Valentina , Lim Emerson , Nowakowski Grzegorz , Cordoba Raul , Morillo Daniel , Valencia Ray , Genvresse Isabelle , Merz Claudia , Boix Oliver , Frigault Melanie M. , Greer Joy M. , Hamdy Ahmed M. , Huang Xin , Izumi Raquel , Wong Harvey , Moreno Victor
Published: April 2023

Supplementary Figure from First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy
Supplementary Figure from Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial
Authors: Majem Margarita , Goldman Jonathan W. , John Thomas , Grohe Christian , Laktionov Konstantin , Kim Sang-We , Kato Terufumi , Vu Huu Vinh , Lu Shun , Li Shanqing , Lee Kye Young , Akewanlop Charuwan , Yu Chong-Jen , de Marinis Filippo , Bonanno Laura , Domine Manuel , Shepherd Frances A. , Atagi Shinji , Zeng Lingmin , Kulkarni Dakshayini , Medic Nenad , Tsuboi Masahiro , Herbst Roy S. , Wu Yi-Long
Published: April 2023

Supplementary Figure from Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial
Supplementary Table from Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer
Authors: Seeber Andreas , Battaglin Francesca , Zimmer Kai , Kocher Florian , Baca Yasmine , Xiu Joanne , Spizzo Gilbert , Novotny-Diermayr Veronica , Rieder Dietmar , Puccini Alberto , Swensen Jeff , Ellis Michelle , Goldberg Richard M. , Grothey Axel , Shields Anthony F. , Marshall John L. , Weinberg Benjamin A. , Sackstein Paul E. , Lim Kiat Hon , Tan Gek San , Nabhan Chadi , Korn W. Michael , Amann Arno , Trajanoski Zlatko , Berger Martin D. , Lou Emil , Wolf Dominik , Lenz Heinz-Josef
Published: April 2023

Supplementary Table from Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer
Supplementary Data from Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapies
Authors: Kudo Masatoshi , Montal Robert , Finn Richard S. , Castet Florian , Ueshima Kazuomi , Nishida Naoshi , Haber Philipp K. , Hu Youyou , Chiba Yasutaka , Schwartz Myron , Meyer Tim , Lencioni Riccardo , Llovet Josep M.
Published: April 2023

Supplementary Data from Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapies
Supplementary Table from Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma
Authors: Klemen Nicholas D. , Hwang Sinchun , Bradic Martina , Rosenbaum Evan , Dickson Mark A. , Gounder Mrinal M. , Kelly Ciara M. , Keohan Mary L. , Movva Sujana , Thornton Katherine A. , Chi Ping , Nacev Benjamin A. , Chan Jason E. , Bartlett Edmund K. , Richards Allison L. , Singer Samuel , Donoghue Mark T.A. , Tap William D. , D'Angelo Sandra P.
Published: April 2023

Supplementary Table from Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma
Supplementary Figure from Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma
Authors: Klemen Nicholas D. , Hwang Sinchun , Bradic Martina , Rosenbaum Evan , Dickson Mark A. , Gounder Mrinal M. , Kelly Ciara M. , Keohan Mary L. , Movva Sujana , Thornton Katherine A. , Chi Ping , Nacev Benjamin A. , Chan Jason E. , Bartlett Edmund K. , Richards Allison L. , Singer Samuel , Donoghue Mark T.A. , Tap William D. , D'Angelo Sandra P.
Published: April 2023

Supplementary Figure from Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma
Supplementary Figure from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Authors: Cheng Vinton W.T. , de Pennington Nicholas , Zakaria Rasheed , Larkin James R. , Serres Sébastien , Sarkar Manjima , Kirkman Matthew A. , Bristow Claire , Croal Paula , Plaha Puneet , Campo Leticia , Chappell Michael A. , Lord Simon , Jenkinson Michael D. , Middleton Mark R. , Sibson Nicola R.
Published: April 2023

Supplementary Figure from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Supplemental Figure S1 from Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy
Authors: Wainberg Zev A. , Singh Arun S. , Konecny Gottfried E. , McCann Kelly E. , Hecht J. Randolph , Goldman Jonathan , Chmielowski Bartosz , Finn Richard S. , O'Brien Neil , Von Euw Erika , Price Megan M. , Martinez Diego , Yonemoto Lisa , Brennan Meghan , Glaspy John A. , Slamon Dennis J.
Published: April 2023

Supplemental Figure S1. Mean pharmacokinetic profiles for single agent talazoparib (BMN673 in phase I clinical trial PRP-001) versus combination therapy.
Supplementary Figure S2 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
Authors: Hebron Katie E. , Wan Xiaolin , Roth Jacob S. , Liewehr David J. , Sealover Nancy E. , Frye William J.E. , Kim Angela , Stauffer Stacey , Perkins Olivia L. , Sun Wenyue , Isanogle Kristine A. , Robinson Christina M. , James Amy , Awasthi Parirokh , Shankarappa Priya , Luo Xiaoling , Lei Haiyan , Butcher Donna , Smith Roberta , Edmondson Elijah F. , Chen Jin-Qiu , Kedei Noemi , Peer Cody J. , Shern Jack F. , Figg W. Douglas , Chen Lu , Hall Matthew D. , Difilippantonio Simone , Barr Frederic G. , Kortum Robert L. , Robey Robert W. , Vaseva Angelina V. , Khan Javed , Yohe Marielle E.
Published: April 2023

The combination of trametinib and ganitumab does not induce hyperinsulinemia or hematologic adverse events in SCID beige mice
Supplementary Figure from Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice
Authors: Park Wungki , O'Connor Catherine A. , Bandlamudi Chaitanya , Forman Daniella , Chou Joanne F. , Umeda Shigeaki , Reyngold Marsha , Varghese Anna M. , Keane Fergus , Balogun Fiyinfolu , Yu Kenneth H. , Kelsen David P. , Crane Christopher , Capanu Marinela , Iacobuzio-Donahue Christine , O'Reilly Eileen M.
Published: April 2023

Supplementary Figure from Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice
Supplementary Figure from Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing
Authors: Hiatt Joseph B. , Sandborg Holly , Garrison Sarah M. , Arnold Henry U. , Liao Sheng-You , Norton Justin P. , Friesen Travis J. , Wu Feinan , Sutherland Kate D. , Rienhoff Hugh Y. , Martins Renato , Houghton A. McGarry , Srivastava Shivani , MacPherson David
Published: April 2023

Supplementary Figure from Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing
Supplementary Data from SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis–Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer
Authors: Swami Umang , Graf Ryon P. , Nussenzveig Roberto H. , Fisher Virginia , Tukachinsky Hanna , Schrock Alexa B. , Li Gerald , Ross Jeffrey S. , Sayegh Nicolas , Tripathi Nishita , Mathew Thomas Vinay , Oxnard Geoffrey R. , Antonarakis Emmanuel S. , Agarwal Neeraj
Published: April 2023

Supplementary Data from SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis–Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer
Supplementary Tables S1-S4 from Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)
Authors: Moyers Justin T. , Pestana Roberto Carmagnani , Roszik Jason , Hong David S. , Naing Aung , Fu Siqing , Piha-Paul Sarina , Yap Timothy A. , Karp Daniel , Rodon Jordi , Livingston Andy , Zarzour Maria Alejandra , Ravi Vinod , Patel Shreyaskumar , Benjamin Robert S. , Ludwig Joseph , Herzog Cynthia , Ratan Ravin , Somaiah Neeta , Conley Anthony , Gorlick Richard , Meric-Bernstam Funda , Subbiah Vivek
Published: April 2023

Supplement Table 1: Histologic Make-up of common sarcomas Supplement Table 2: List of common alterations among URS population by frequency Supplement Table 3: Sarcomas experiencing without clinical benefit (e.g. SD for <6 months or PD as best response) Supplement Table 4: Immunotherapy Responses and Clinical Benefit
Supplementary Figure 1 from Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated SPP1+ Macrophages and Fibroblasts
Authors: Sathe Anuja , Mason Kaishu , Grimes Susan M. , Zhou Zilu , Lau Billy T. , Bai Xiangqi , Su Andrew , Tan Xiao , Lee HoJoon , Suarez Carlos J. , Nguyen Quan , Poultsides George , Zhang Nancy R. , Ji Hanlee P.
Published: April 2023

(A) UMAP representation of dimensionally reduced data following batch-corrected graph-based clustering of all tumor epithelial cells annotated by sample. (B)
Heatmap depicting expression of five highest significantly expressed genes (adjusted p-value <0.05) per patient. (C) Heatmap representation of inferred single-cell CNV profiles of all tumors and reference cells. (A-C) Data from seven mCRCs.
Supplementary Table from Osimertinib plus Selumetinib in EGFR-Mutated Non–Small Cell Lung Cancer After Progression on EGFR-TKIs: A Phase Ib, Open-Label, Multicenter Trial (TATTON Part B)
Authors: Yang James Chih-Hsin , Ohe Yuichiro , Chiu Chao-Hua , Ou Xiaoling , Cantarini Mireille , Jänne Pasi A. , Hartmaier Ryan J. , Ahn Myung Ju
Published: April 2023

Supplementary Table from Osimertinib plus Selumetinib in EGFR-Mutated Non–Small Cell Lung Cancer After Progression on EGFR-TKIs: A Phase Ib, Open-Label, Multicenter Trial (TATTON Part B)
Supplementary Table from miR-196b–TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AML
Authors: Gamlen Holly A. , Romer-Seibert Jennifer S. , Lawler Michael E. , Versace Amanda M. , Goetz Melanie L. , Feng Yang , Guryanova Olga A. , Palmisiano Neil , Meyer Sara E.
Published: April 2023

Supplementary Table from miR-196b–TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AML
Supplementary Figures S1-S8 from Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer
Authors: Rochigneux Philippe , Lisberg Aaron , Garcia Alejandro , Granjeaud Samuel , Madroszyk Anne , Fattori Stéphane , Gonçalves Anthony , Devillier Raynier , Maby Pauline , Salem Nassim , Gorvel Laurent , Chanez Brice , Gukasyan Jaklin , Carroll James , Goldman Jonathan , Chretien Anne Sophie , Olive Daniel , Garon Edward B.
Published: April 2023

Supplementary Figure 1: Graphical Abstract
Supplementary Figure 2: Overall Survival in NSCLC patients treated with pembrolizumab in KEYNOTE-001 according to EGFR mutation
Supplementary Figure 3: Recursive partitioning identified classical monocytes and NK as the main immune populations whose frequency splits patients into distinct patterns of overall survival
Supplementary Figure 4: Classical monocytes, NK cells and ICOS+ CD4+ T cells are associated with improved pembrolizumab efficacy in advanced NSCLC patients.
Supplementary Figure 5: Gating strategy of the 3 main immune populations associated with pembrolizumab efficacy.
Supplementary Figure 6: Comparison side by side of Maxstat cut-offs with cut-off from Younden index for overall survival in the 3 populations of interest.
Supplementary Figure 7: Survival outcomes in NSCLC patients treated with pembrolizumab in KEYNOTE-001 according to blood baseline frequency of classical monocytes.
Supplementary Figure 8: Baseline immune peripheral score is also associated with PFS in melanoma patients treated with PD-1 inhibitors.
Figure S3 from Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
Authors: Kang Kyung-Don , Bernstock Joshua D. , Totsch Stacie K. , Gary Sam E. , Rocco Abbey , Nan Li , Li Rong , Etminan Tina , Han Xiaosi , Beierle Elizabeth A. , Eisemann Tanja , Wechsler-Reya Robert J. , Bae Sejong , Whitley Richard , Gillespie G. Yancey , Markert James M. , Friedman Gregory K.
Published: April 2023

IHC staining of the ependymal lining for CD8+ cells and confirmation of CD8 depletion.
Figure S2 from Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
Authors: Kang Kyung-Don , Bernstock Joshua D. , Totsch Stacie K. , Gary Sam E. , Rocco Abbey , Nan Li , Li Rong , Etminan Tina , Han Xiaosi , Beierle Elizabeth A. , Eisemann Tanja , Wechsler-Reya Robert J. , Bae Sejong , Whitley Richard , Gillespie G. Yancey , Markert James M. , Friedman Gregory K.
Published: April 2023

Toxicity from IVT oHSV in the left lateral ventricle and third and fourth ventricles at different time points.
Supplementary Table from De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial
Authors: Gluz Oleg , Nitz Ulrike , Kolberg-Liedtke Cornelia , Prat Aleix , Christgen Matthias , Kuemmel Sherko , Mohammadian Mohammad Parsa , Gebauer Daniel , Kates Ronald , Paré Laia , Grischke Eva-Maria , Forstbauer Helmut , Braun Michael , Warm Mathias , Hackmann John , Uleer Christoph , Aktas Bahriye , Schumacher Claudia , Wuerstlein Rachel , Graeser Monika , Pelz Enrico , Jóźwiak Katarzyna , zu Eulenburg Christine , Kreipe Hans Heinrich , Harbeck Nadia
Published: April 2023

Supplementary Table from De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial
Supplementary Figure from De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial
Authors: Gluz Oleg , Nitz Ulrike , Kolberg-Liedtke Cornelia , Prat Aleix , Christgen Matthias , Kuemmel Sherko , Mohammadian Mohammad Parsa , Gebauer Daniel , Kates Ronald , Paré Laia , Grischke Eva-Maria , Forstbauer Helmut , Braun Michael , Warm Mathias , Hackmann John , Uleer Christoph , Aktas Bahriye , Schumacher Claudia , Wuerstlein Rachel , Graeser Monika , Pelz Enrico , Jóźwiak Katarzyna , zu Eulenburg Christine , Kreipe Hans Heinrich , Harbeck Nadia
Published: April 2023

Supplementary Figure from De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial
Supplementary Data from De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial
Authors: Gluz Oleg , Nitz Ulrike , Kolberg-Liedtke Cornelia , Prat Aleix , Christgen Matthias , Kuemmel Sherko , Mohammadian Mohammad Parsa , Gebauer Daniel , Kates Ronald , Paré Laia , Grischke Eva-Maria , Forstbauer Helmut , Braun Michael , Warm Mathias , Hackmann John , Uleer Christoph , Aktas Bahriye , Schumacher Claudia , Wuerstlein Rachel , Graeser Monika , Pelz Enrico , Jóźwiak Katarzyna , zu Eulenburg Christine , Kreipe Hans Heinrich , Harbeck Nadia
Published: April 2023

Supplementary Data from De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial
Supplementary Figures S1-S13 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Authors: Meagher Nicola S. , Gorringe Kylie L. , Wakefield Matthew , Bolithon Adelyn , Pang Chi Nam Ignatius , Chiu Derek S. , Anglesio Michael S. , Mallitt Kylie-Ann , Doherty Jennifer A. , Harris Holly R. , Schildkraut Joellen M. , Berchuck Andrew , Cushing-Haugen Kara L. , Chezar Ksenia , Chou Angela , Tan Adeline , Alsop Jennifer , Barlow Ellen , Beckmann Matthias W. , Boros Jessica , Bowtell David D.L. , Brand Alison H. , Brenton James D. , Campbell Ian , Cheasley Dane , Cohen Joshua , Cybulski Cezary , Elishaev Esther , Erber Ramona , Farrell Rhonda , Fischer Anna , Fu Zhuxuan , Gilks Blake , Gill Anthony J. , Gourley Charlie , Grube Marcel , Harnett Paul R. , Hartmann Arndt , Hettiaratchi Anusha , Høgdall Claus K. , Huzarski Tomasz , Jakubowska Anna , Jimenez-Linan Mercedes , Kennedy Catherine J. , Kim Byoung-Gie , Kim Jae-Weon , Kim Jae-Hoon , Klett Kayla , Koziak Jennifer M. , Lai Tiffany , Laslavic Angela , Lester Jenny , Leung Yee , Li Na , Liauw Winston , Lim Belle W.X. , Linder Anna , Lubiński Jan , Mahale Sakshi , Mateoiu Constantina , McInerny Simone , Menkiszak Janusz , Minoo Parham , Mittelstadt Suzana , Morris David , Orsulic Sandra , Park Sang-Yoon , Pearce Celeste Leigh , Pearson John V. , Pike Malcolm C. , Quinn Carmel M. , Mohan Ganendra Raj , Rao Jianyu , Riggan Marjorie J. , Ruebner Matthias , Salfinger Stuart , Scott Clare L. , Shah Mitul , Steed Helen , Stewart Colin J.R. , Subramanian Deepak , Sung Soseul , Tang Katrina , Timpson Paul , Ward Robyn L. , Wiedenhoefer Rebekka , Thorne Heather , Cohen Paul A. , Crowe Philip , Fasching Peter A. , Gronwald Jacek , Hawkins Nicholas J. , Høgdall Estrid , Huntsman David G. , James Paul A. , Karlan Beth Y. , Kelemen Linda E. , Kommoss Stefan , Konecny Gottfried E. , Modugno Francesmary , Park Sue K. , Staebler Annette , Sundfeldt Karin , Wu Anna H. , Talhouk Aline , Pharoah Paul D.P. , Anderson Lyndal , DeFazio Anna , Köbel Martin , Friedlander Michael L. , Ramus Susan J.
Published: April 2023

Supplementary Figures S1-S13
Supplementary Data1 from Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation
Authors: Shouval Roni , Waters Nicholas R. , Gomes Antonio L. C. , Zuanelli Brambilla Corrado , Fei Teng , Devlin Sean M. , Nguyen Chi L. , Markey Kate A. , Dai Anqi , Slingerland John B. , Clurman Annelie G. , Fontana Emily , Amoretti Luigi A. , Wright Roberta J. , Hohl Tobias M. , Taur Ying , Sung Anthony D. , Weber Daniela , Hashimoto Daigo , Teshima Takanori , Chao Nelson J. , Holler Ernst , Scordo Michael , Giralt Sergio A. , Perales Miguel-Angel , Peled Jonathan U. , van den Brink Marcel R.M.
Published: April 2023

Supplementary Data
Supplementary Figure from PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC
Authors: Hummelink Karlijn , van der Noort Vincent , Muller Mirte , Schouten Robert D. , Lalezari Ferry , Peters Dennis , Theelen Willemijn S.M.E. , Koelzer Viktor H. , Mertz Kirsten D. , Zippelius Alfred , van den Heuvel Michel M. , Broeks Annegien , Haanen John B.A.G. , Schumacher Ton N. , Meijer Gerrit A. , Smit Egbert F. , Monkhorst Kim , Thommen Daniela S.
Published: April 2023

Supplementary Figure from PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC
Supplementary Figure from Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents
Authors: Torrens Laura , Puigvehí Marc , Torres-Martín Miguel , Wang Huan , Maeda Miho , Haber Philipp K. , Leonel Thais , García-López Mireia , Esteban-Fabró Roger , Leow Wei Qiang , Montironi Carla , Torrecilla Sara , Varadarajan Ajay Ramakrishnan , Taik Patricia , Campreciós Genís , Enkhbold Chinbold , Taivanbaatar Erdenebileg , Yerbolat Amankyeldi , Villanueva Augusto , Pérez-del-Pulgar Sofía , Thung Swan , Chinburen Jigjidsuren , Letouzé Eric , Zucman-Rossi Jessica , Uzilov Andrew , Neely Jaclyn , Forns Xavier , Roayaie Sasan , Sia Daniela , Llovet Josep M.
Published: April 2023

Supplementary Figure from Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents
Supplementary Tables 1 and 6-8 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
Authors: Hahn Andrew W. , Menk Ashley V. , Rivadeneira Dayana B. , Augustin Ryan C. , Xu Mingchu , Li Jun , Wu Xiaogang , Mishra Aditya K. , Gide Tuba N. , Quek Camelia , Zang Yan , Spencer Christine N. , Menzies Alexander M. , Daniel Carrie R. , Hudgens Courtney W. , Nowicki Theodore , Haydu Lauren E. , Khan M.A. Wadud , Gopalakrishnan Vancheswaran , Burton Elizabeth M. , Malke Jared , Simon Julie M. , Bernatchez Chantale , Putluri Nagireddy , Woodman Scott E. , Vashisht Gopal Y.N. , Guerrieri Renato , Fischer Grant M. , Wang Jian , Wani Khalida M. , Thompson John F. , Lee Jeffrey E. , Hwu Patrick , Ajami Nadim , Gershenwald Jeffrey E. , Long Georgina V. , Scolyer Richard A. , Tetzlaff Michael T. , Lazar Alexander J. , Schadendorf Dirk , Wargo Jennifer A. , Kirkwood John M. , DeBerardinis Ralph J. , Liang Han , Futreal Andrew , Zhang Jianhua , Wilmott James S. , Peng Weiyi , Davies Michael A. , Delgoffe Greg M. , Najjar Yana G. , McQuade Jennifer L.
Published: April 2023

Supplementary Table 1: Baseline characteristics for patients included in the integrated gene set enrichment analysis (Figure 2-3) by cohort; Supplementary Table 6: The most frequent somatic alterations (alts) in patients with regionally metastatic melanoma by body mass index from The Cancer Genome Atlas cohort; Supplemental Table 7: Integrated gene set enrichment analysis for pathways associated with fatty acid metabolism by body mass index; Supplemental Table 8: Gene expression of selected genes of interest involved in fatty acid metabolism.
Supplementary Figure from Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma
Authors: Dong Pei , Zhang Xinyue , Peng Yulu , Zhang Yijun , Liu Ruiqi , Li Yilin , Pan Qiwen , Wei Wensu , Guo Shengjie , Zhang Zhiling , Han Hui , Zhou Fangjian , Liu Yang , He Liru
Published: April 2023

Supplementary Figure from Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma
Supplementary Table 2 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
Authors: Hahn Andrew W. , Menk Ashley V. , Rivadeneira Dayana B. , Augustin Ryan C. , Xu Mingchu , Li Jun , Wu Xiaogang , Mishra Aditya K. , Gide Tuba N. , Quek Camelia , Zang Yan , Spencer Christine N. , Menzies Alexander M. , Daniel Carrie R. , Hudgens Courtney W. , Nowicki Theodore , Haydu Lauren E. , Khan M.A. Wadud , Gopalakrishnan Vancheswaran , Burton Elizabeth M. , Malke Jared , Simon Julie M. , Bernatchez Chantale , Putluri Nagireddy , Woodman Scott E. , Vashisht Gopal Y.N. , Guerrieri Renato , Fischer Grant M. , Wang Jian , Wani Khalida M. , Thompson John F. , Lee Jeffrey E. , Hwu Patrick , Ajami Nadim , Gershenwald Jeffrey E. , Long Georgina V. , Scolyer Richard A. , Tetzlaff Michael T. , Lazar Alexander J. , Schadendorf Dirk , Wargo Jennifer A. , Kirkwood John M. , DeBerardinis Ralph J. , Liang Han , Futreal Andrew , Zhang Jianhua , Wilmott James S. , Peng Weiyi , Davies Michael A. , Delgoffe Greg M. , Najjar Yana G. , McQuade Jennifer L.
Published: April 2023

Differential gene expression analysis for covariates controlled.
Supplementary Data from Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma
Authors: Dong Pei , Zhang Xinyue , Peng Yulu , Zhang Yijun , Liu Ruiqi , Li Yilin , Pan Qiwen , Wei Wensu , Guo Shengjie , Zhang Zhiling , Han Hui , Zhou Fangjian , Liu Yang , He Liru
Published: April 2023

Supplementary Data from Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma
Supplementary Figure S3 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
Authors: Hahn Andrew W. , Menk Ashley V. , Rivadeneira Dayana B. , Augustin Ryan C. , Xu Mingchu , Li Jun , Wu Xiaogang , Mishra Aditya K. , Gide Tuba N. , Quek Camelia , Zang Yan , Spencer Christine N. , Menzies Alexander M. , Daniel Carrie R. , Hudgens Courtney W. , Nowicki Theodore , Haydu Lauren E. , Khan M.A. Wadud , Gopalakrishnan Vancheswaran , Burton Elizabeth M. , Malke Jared , Simon Julie M. , Bernatchez Chantale , Putluri Nagireddy , Woodman Scott E. , Vashisht Gopal Y.N. , Guerrieri Renato , Fischer Grant M. , Wang Jian , Wani Khalida M. , Thompson John F. , Lee Jeffrey E. , Hwu Patrick , Ajami Nadim , Gershenwald Jeffrey E. , Long Georgina V. , Scolyer Richard A. , Tetzlaff Michael T. , Lazar Alexander J. , Schadendorf Dirk , Wargo Jennifer A. , Kirkwood John M. , DeBerardinis Ralph J. , Liang Han , Futreal Andrew , Zhang Jianhua , Wilmott James S. , Peng Weiyi , Davies Michael A. , Delgoffe Greg M. , Najjar Yana G. , McQuade Jennifer L.
Published: April 2023

Integrated gene set enrichment analysis of subgroups by body mass index BMI. This figure compares gene expression between overweight/obese (OW/OB) and normal (NL) BMI patients with metastatic melanoma across subgroups by sex, cohort, and tissue site. Supplementary Figure 2 presents a dotplot of genes differentially up- or downregulated in OW/OB patients versus NL BMI patients by subgroups. Red indicates upregulation in OW/OB verse NL.
Supplementary Table 4 from Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience
Authors: Marmouset Vincent , Decroocq Justine , Garciaz Sylvain , Etienne Gabriel , Belhabri Amine , Bertoli Sarah , Gastaud Lauris , Simand Célestine , Chantepie Sylvain , Uzunov Madalina , Genthon Alexis , Berthon Céline , Chiche Edmond , Dumas Pierre-Yves , Vargaftig Jacques , Salmeron Géraldine , Lemasle Emilie , Tavernier Emmanuelle , Delage Jérémy , Loirat Marion , Morineau Nadine , Blanc-Durand Félix , Pautier Patricia , Vergé Véronique , Auger Nathalie , Thomas Myrtille , Stefani Laetitia , Lepelley Marion , Boyer Thomas , Thepot Sylvain , Gourin Marie-Pierre , Bourquard Pascal , Duchmann Matthieu , Morice Pierre-Marie , Michallet Mauricette , Adès Lionel , Fenaux Pierre , Récher Christian , Dombret Hervé , Pagès Arnaud , Marzac Christophe , Leary Alexandra , Micol Jean-Baptiste
Published: April 2023

Patient characteristics of the national cohort according to the type of PARPi received (olaparib vs. other PARP inhibitors).
Supplementary Figure 4 from Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience
Authors: Marmouset Vincent , Decroocq Justine , Garciaz Sylvain , Etienne Gabriel , Belhabri Amine , Bertoli Sarah , Gastaud Lauris , Simand Célestine , Chantepie Sylvain , Uzunov Madalina , Genthon Alexis , Berthon Céline , Chiche Edmond , Dumas Pierre-Yves , Vargaftig Jacques , Salmeron Géraldine , Lemasle Emilie , Tavernier Emmanuelle , Delage Jérémy , Loirat Marion , Morineau Nadine , Blanc-Durand Félix , Pautier Patricia , Vergé Véronique , Auger Nathalie , Thomas Myrtille , Stefani Laetitia , Lepelley Marion , Boyer Thomas , Thepot Sylvain , Gourin Marie-Pierre , Bourquard Pascal , Duchmann Matthieu , Morice Pierre-Marie , Michallet Mauricette , Adès Lionel , Fenaux Pierre , Récher Christian , Dombret Hervé , Pagès Arnaud , Marzac Christophe , Leary Alexandra , Micol Jean-Baptiste
Published: April 2023

Commutation plot visualizing the mutated genes in t-MN after OC according to PARPi treatment.
Supplementary Table S2 from Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation
Authors: Serra-Camprubí Queralt , Verdaguer Helena , Oliveros Winona , Lupión-Garcia Núria , Llop-Guevara Alba , Molina Cristina , Vila-Casadesús Maria , Turpin Anthony , Neuzillet Cindy , Frigola Joan , Querol Jessica , Yáñez-Bartolomé Mariana , Castet Florian , Fabregat-Franco Carles , Escudero-Iriarte Carmen , Escorihuela Marta , Arenas Enrique J. , Bernadó-Morales Cristina , Haro Noemí , Giles Francis J. , Pozo Óscar J. , Miquel Josep M. , Nuciforo Paolo G. , Vivancos Ana , Melé Marta , Serra Violeta , Arribas Joaquín , Tabernero Josep , Peiró Sandra , Macarulla Teresa , Tian Tian V.
Published: April 2023

Information of patients underwent the biopsy procedures.
Supplementary Figure S5 from Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation
Authors: Serra-Camprubí Queralt , Verdaguer Helena , Oliveros Winona , Lupión-Garcia Núria , Llop-Guevara Alba , Molina Cristina , Vila-Casadesús Maria , Turpin Anthony , Neuzillet Cindy , Frigola Joan , Querol Jessica , Yáñez-Bartolomé Mariana , Castet Florian , Fabregat-Franco Carles , Escudero-Iriarte Carmen , Escorihuela Marta , Arenas Enrique J. , Bernadó-Morales Cristina , Haro Noemí , Giles Francis J. , Pozo Óscar J. , Miquel Josep M. , Nuciforo Paolo G. , Vivancos Ana , Melé Marta , Serra Violeta , Arribas Joaquín , Tabernero Josep , Peiró Sandra , Macarulla Teresa , Tian Tian V.
Published: April 2023

Absence of PARP inhibitor efficacy in IDH1mut, ARID1Amut, or BAP1mut CCA_PDXs. (A) Dose-response curves of niraparib for a panel of tumoroids derived from CCA_PDXs. Cell viability was determined using Cell Titer-Glo assay 7 days after the treatment initiation. Data are mean ± s.d. from independent biological replicates. PDX41, n=3; PDX78, n=3; PDX85, n=6; PDX75, n=2; PDX75.2, n=2; PDX118, n=3; PDX133, n=3. (B) Half-maximal inhibitory concentration (IC50) of niraparib in tumoroids derived from CCA_PDXs. (C) Representative images of immunohistochemical staining for a cell proliferation marker (Ki67) and apoptosis marker cleaved caspase 3 in PDX85 cells treated as for Fig 4C. (D) Representative images of immunohistochemical staining for cell proliferation marker (Ki67) and apoptosis marker cleaved caspase 3 in PDX78 treated as for Fig 4D. Scale bar, 250 µm.
Supplementary Data TS1 from Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
Authors: Liu Xin , Jiang Shiyu , Wang Huijie , Wu Xianghua , Yan Wangjun , Chen Yong , Xu Yu , Wang Chunmeng , Yao Weiqiang , Wang Jian , Yu Lin , Miao Jiashun , Chen Hao , Xia Jing , Huang Mengli , Zhang Xiaowei , Luo Zhiguo
Published: April 2023

supplementary tables
Supplementary Table from 89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma
Authors: Lee Yu-Jin , van den Berg Nynke S. , Duan Heying , Azevedo E. Carmen , Ferri Valentina , Hom Marisa , Raymundo Roan C. , Valencia Alex , Castillo Jessa , Shen Bin , Zhou Quan , Freeman Laura , Koran Mary Ellen , Kaplan Michael J. , Colevas A. Dimitrios , Baik Fred M. , Chin Frederick T. , Martin Brock A. , Iagaru Andrei , Rosenthal Eben L.
Published: April 2023

Supplementary Table from 89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma
Supplementary Figure from 89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma
Authors: Lee Yu-Jin , van den Berg Nynke S. , Duan Heying , Azevedo E. Carmen , Ferri Valentina , Hom Marisa , Raymundo Roan C. , Valencia Alex , Castillo Jessa , Shen Bin , Zhou Quan , Freeman Laura , Koran Mary Ellen , Kaplan Michael J. , Colevas A. Dimitrios , Baik Fred M. , Chin Frederick T. , Martin Brock A. , Iagaru Andrei , Rosenthal Eben L.
Published: April 2023

Supplementary Figure from 89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma
Supplementary Figure S2 from [89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma
Authors: Verhoeff Sarah R. , Oosting Sjoukje F. , Elias Sjoerd G. , van Es Suzanne C. , Gerritse Sophie L. , Angus Lindsay , Heskamp Sandra , Desar Ingrid M.E. , Menke-van der Houven van Oordt C. Willemien , van der Veldt Astrid A.M. , Arens Anne I.J. , Brouwers Adrienne H. , Eisses Bertha , Mulders Peter F.A. , Hoekstra Otto S. , Zwezerijnen Gerben J.C. , van der Graaf Winette T.A. , Aarntzen Erik H.J.G. , Oyen Wim J.G. , van Herpen Carla M.L.
Published: April 2023

Score chart with predicted probability (%) to remain on WW at 12 months This model was based on the number of IMDC Risk factors (0, 1, 2), the number or involved organ sites (0 - 4) and the geometric mean [¹⁸F]FDG SUVmax as a continuous variable. The underlying formula is 100*(exp(-0.531)^exp(0.198*[IMDC score] + 0.039*[No of affected organ sites] + 0.170*[geometric mean [¹⁸F]FDG SUVmax] - 1.09))
Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer
Authors: Ruggieri Amanda N. , Yarchoan Mark , Goyal Subir , Liu Yuan , Sharon Elad , Chen Helen X. , Olson Brian M. , Paulos Chrystal M. , El-Rayes Bassel F. , Maithel Shishir K. , Azad Nilofer S. , Lesinski Gregory B.
Published: April 2023

Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer
Supplementary Table from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
Authors: Termini Rosalinda , Žihala David , Terpos Evangelos , Perez-Montaña Albert , Jelínek Tomáš , Raab Marc , Weinhold Niels , Mai Elias K. , Grab Anna Luise , Corre Jill , Vergez Francois , Sacco Antonio , Chiarini Marco , Giustini Viviana , Tucci Alessandra , Rodriguez Sara , Moreno Cristina , Perez Cristina , Maia Catarina , Martín-Sánchez Esperanza , Guerrero Camilla , Botta Cirino , Garces Juan-Jose , Lopez Aitziber , Tamariz-Amador Luis-Esteban , Prosper Felipe , Bargay Joan , Cabezudo Maria-Elena , Ocio Enrique M. , Hájek Roman , Martinez-Lopez Joaquin , Solano Fernando , Iglesias Rebeca , Paiva Artur , Geraldes Catarina , Vitoria Helena , Gomez Clara , De Arriba Felipe , Ludwig Heinz , Garcia-Guiñon Antoni , Casanova Maria , Alegre Adrian , Cabañas Valentin , Sirvent Maialen , Oriol Albert , de la Rubia Javier , Hernández-Rivas José-Ángel , Palomera Luis , Sarasa Maria , Rios Pablo , Puig Noemi , Mateos Maria-Victoria , Flores-Montero Juan , Orfao Alberto , Goldschmidt Hartmut , Avet-Loiseau Hervé , Roccaro Aldo M. , San-Miguel Jesus F. , Paiva Bruno
Published: April 2023

Supplementary Table from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
Supplementary Tables S1-14 from Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial
Authors: Albanell Joan , Pérez-García José Manuel , Gil-Gil Miguel , Curigliano Giuseppe , Ruíz-Borrego Manuel , Comerma Laura , Gibert Joan , Bellet Meritxell , Bermejo Begoña , Calvo Lourdes , de la Haba Juan , Espinosa Enrique , Minisini Alessandro Marco , Quiroga Vanesa , Santaballa Bertran Ana , Mina Leonardo , Bellosillo Beatriz , Rojo Federico , Menéndez Silvia , Sampayo-Cordero Miguel , Popa Crina , Malfettone Andrea , Cortés Javier , Llombart-Cussac Antonio
Published: April 2023

Supplementary Table S1. Selection Criteria; Supplementary Table S2. Recruiting Sites, Principal Investigators, and Patient Numbers; Supplementary Table S3. Study Members; Supplementary Table S4. List of antibodies used for immunohistochemistry analysis; Supplementary Table S5. Cutoff values for the quantitative assessment of biomarkers by immunohistochemistry; Supplementary Table S6. The 77-gene panel by the AVENIO ctDNA Expanded Kit used for targeted NGS on plasma samples; Supplementary Table S7. Representativeness of study participants; Supplementary Table S8. Association of baseline clinical and pathologic characteristics of trial participants included in the efficacy analysis with clinical benefit; Supplementary Table S9. Relative dose intensity and drug discontinuation; Supplementary Table S10. All causality AEs according to NCI-CTCAE version 4.0.3 occurring in at least 5% of the patients; Supplementary Table S11. Adverse events of special interest according to NCI-CTCAE version 4.0.3; Supplementary Table S12. Baseline clinical and pathologic characteristics of trial participants included in the retinoblastoma and signature subsets; Supplementary Table S13. Tumor best response according to RECIST version 1.1 of trial participants included in the retinoblastoma and signature subsets; Supplementary Table S14. Association of biomarkers and composite signatures with clinical benefit.
Supplementary Table 3 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
Authors: Mierzwa Michelle L. , Aryal Madhava , Lee Choonik , Schipper Matthew , VanTil Monica , Morales Krystal , Swiecicki Paul L. , Casper Keith A. , Malloy Kelly M. , Spector Matthew E. , Shuman Andrew G. , Chinn Steven B. , Prince Mark E.P. , Stucken Chaz L. , Rosko Andrew J. , Lawrence Theodore S. , Brenner J. Chad , Rosen Benjamin , Schonewolf Caitlin A. , Shah Jennifer , Eisbruch Avraham , Worden Francis P. , Cao Yue
Published: April 2023

Multi-variable model for loco-regional control in randomized patients including covariates of chemotherapy regimen and smoking history
Supplementary Figure from A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses
Authors: Irajizad Ehsan , Han Chae Y. , Celestino Joseph , Wu Ranran , Murage Eunice , Spencer Rachelle , Dennison Jennifer B. , Vykoukal Jody , Long James P. , Do Kim Anh , Drescher Charles , Lu Karen , Lu Zhen , Bast Robert C. , Hanash Sam , Fahrmann Johannes F.
Published: April 2023

Supplementary Figure from A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses
Supplementary Data from Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns
Authors: Mair Maximilian J. , Leibetseder Annette , Heller Gerwin , Puhr Rainer , Tomasich Erwin , Goldberger Sebastian , Hatziioannou Teresa , Wöhrer Adelheid , Widhalm Georg , Dieckmann Karin , Aichholzer Martin , Weis Serge , von Oertzen Tim , Furtner Julia , Pichler Josef , Preusser Matthias , Berghoff Anna S.
Published: April 2023

Supplementary Data from Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns
Supplementary Table 1 from Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis
Authors: Kfir-Erenfeld Shlomit , Asherie Nathalie , Grisariu Sigal , Avni Batia , Zimran Eran , Assayag Miri , Sharon Tatyana Dubnikov , Pick Marjorie , Lebel Eyal , Shaulov Adir , Cohen Yael C. , Avivi Irit , Cohen Cyrille J. , Stepensky Polina , Gatt Moshe E.
Published: April 2023

Release testing criteria
Supplementary Tables S1-S11 from NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
Authors: Belhadj Sami , Khurram Aliya , Bandlamudi Chaitanya , Palou-Márquez Guillermo , Ravichandran Vignesh , Steinsnyder Zoe , Wildman Temima , Catchings Amanda , Kemel Yelena , Mukherjee Semanti , Fesko Benjamin , Arora Kanika , Mehine Miika , Dandiker Sita , Izhar Aalin , Petrini John , Domchek Susan , Nathanson Katherine L. , Brower Jamie , Couch Fergus , Stadler Zsofia , Robson Mark , Walsh Michael , Vijai Joseph , Berger Michael , Supek Fran , Karam Rachid , Topka Sabine , Offit Kenneth
Published: April 2023

Excel file with all the supplementary tables (S1-S11) in separate tabs
Figure S7 from NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
Authors: Belhadj Sami , Khurram Aliya , Bandlamudi Chaitanya , Palou-Márquez Guillermo , Ravichandran Vignesh , Steinsnyder Zoe , Wildman Temima , Catchings Amanda , Kemel Yelena , Mukherjee Semanti , Fesko Benjamin , Arora Kanika , Mehine Miika , Dandiker Sita , Izhar Aalin , Petrini John , Domchek Susan , Nathanson Katherine L. , Brower Jamie , Couch Fergus , Stadler Zsofia , Robson Mark , Walsh Michael , Vijai Joseph , Berger Michael , Supek Fran , Karam Rachid , Topka Sabine , Offit Kenneth
Published: April 2023

Supplementary Figure S7. NBN Multi-species protein alignment.
Supplementary Figure from Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma
Authors: Tang Xinyi , Yang Zhi-Zhang , Kim Hyo Jin , Anagnostou Theodora , Yu Yue , Wu Xiaosheng , Chen Jun , Krull Jordan E. , Wenzl Kerstin , Mondello Patrizia , Bhardwaj Vaishali , Wang Junwen , Novak Anne J. , Ansell Stephen M.
Published: April 2023

Supplementary Figure from Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma
Figure S6 from NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
Authors: Belhadj Sami , Khurram Aliya , Bandlamudi Chaitanya , Palou-Márquez Guillermo , Ravichandran Vignesh , Steinsnyder Zoe , Wildman Temima , Catchings Amanda , Kemel Yelena , Mukherjee Semanti , Fesko Benjamin , Arora Kanika , Mehine Miika , Dandiker Sita , Izhar Aalin , Petrini John , Domchek Susan , Nathanson Katherine L. , Brower Jamie , Couch Fergus , Stadler Zsofia , Robson Mark , Walsh Michael , Vijai Joseph , Berger Michael , Supek Fran , Karam Rachid , Topka Sabine , Offit Kenneth
Published: April 2023

Supplementary Figure S6. Co-segregation study in families with missense variants identified in >34,000 patients (MSKCC) for which samples from relatives were available.
Figure S4 from NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
Authors: Belhadj Sami , Khurram Aliya , Bandlamudi Chaitanya , Palou-Márquez Guillermo , Ravichandran Vignesh , Steinsnyder Zoe , Wildman Temima , Catchings Amanda , Kemel Yelena , Mukherjee Semanti , Fesko Benjamin , Arora Kanika , Mehine Miika , Dandiker Sita , Izhar Aalin , Petrini John , Domchek Susan , Nathanson Katherine L. , Brower Jamie , Couch Fergus , Stadler Zsofia , Robson Mark , Walsh Michael , Vijai Joseph , Berger Michael , Supek Fran , Karam Rachid , Topka Sabine , Offit Kenneth
Published: April 2023

Supplementary Figure S4. Alternative somatic second hit analysis.
Supplementary Figure from Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfound
Authors: Chi Kim N. , Barnicle Alan , Sibilla Caroline , Lai Zhongwu , Corcoran Claire , Barrett J. Carl , Adelman Carrie A. , Qiu Ping , Easter Ashley , Dearden Simon , Oxnard Geoffrey R. , Agarwal Neeraj , Azad Arun , de Bono Johann , Mateo Joaquin , Olmos David , Thiery-Vuillemin Antoine , Harrington Elizabeth A.
Published: April 2023

Supplementary Figure from Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfound
Figure S8 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
Authors: Ma Yuanqing , Joyce Allison , Brandenburg Olivia , Saatchi Faeze , Stevens Christina , Toffessi Tcheuyap Vanina , Christie Alana , Do Quyen N. , Fatunde Oluwatomilade , Macchiaroli Alyssa , Wong So C. , Woolford Layton , Yousuf Qurratulain , Miyata Jeffrey , Carrillo Deyssy , Onabolu Oreoluwa , McKenzie Tiffani , Mishra Akhilesh , Hardy Tanner , He Wei , Li Daniel , Ivanishev Alexander , Zhang Qing , Pedrosa Ivan , Kapur Payal , Schluep Thomas , Kanner Steven B. , Hamilton James , Brugarolas James
Published: April 2023

Figure S8
Figure S7 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
Authors: Ma Yuanqing , Joyce Allison , Brandenburg Olivia , Saatchi Faeze , Stevens Christina , Toffessi Tcheuyap Vanina , Christie Alana , Do Quyen N. , Fatunde Oluwatomilade , Macchiaroli Alyssa , Wong So C. , Woolford Layton , Yousuf Qurratulain , Miyata Jeffrey , Carrillo Deyssy , Onabolu Oreoluwa , McKenzie Tiffani , Mishra Akhilesh , Hardy Tanner , He Wei , Li Daniel , Ivanishev Alexander , Zhang Qing , Pedrosa Ivan , Kapur Payal , Schluep Thomas , Kanner Steven B. , Hamilton James , Brugarolas James
Published: April 2023

Figure S7
Supplementary Figure from Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes
Authors: Bolton Kelly L. , Chen Denise , Corona de la Fuente Rosario , Fu Zhuxuan , Murali Rajmohan , Köbel Martin , Tazi Yanis , Cunningham Julie M. , Chan Irenaeus C.C. , Wiley Brian J. , Moukarzel Lea A. , Winham Stacey J. , Armasu Sebastian M. , Lester Jenny , Elishaev Esther , Laslavic Angela , Kennedy Catherine J. , Piskorz Anna , Sekowska Magdalena , Brand Alison H. , Chiew Yoke-Eng , Pharoah Paul , Elias Kevin M. , Drapkin Ronny , Churchman Michael , Gourley Charlie , DeFazio Anna , Karlan Beth , Brenton James D. , Weigelt Britta , Anglesio Michael S. , Huntsman David , Gayther Simon , Konner Jason , Modugno Francesmary , Lawrenson Kate , Goode Ellen L. , Papaemmanuil Elli
Published: April 2023

Supplementary Figure from Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes
Figure S4 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
Authors: Ma Yuanqing , Joyce Allison , Brandenburg Olivia , Saatchi Faeze , Stevens Christina , Toffessi Tcheuyap Vanina , Christie Alana , Do Quyen N. , Fatunde Oluwatomilade , Macchiaroli Alyssa , Wong So C. , Woolford Layton , Yousuf Qurratulain , Miyata Jeffrey , Carrillo Deyssy , Onabolu Oreoluwa , McKenzie Tiffani , Mishra Akhilesh , Hardy Tanner , He Wei , Li Daniel , Ivanishev Alexander , Zhang Qing , Pedrosa Ivan , Kapur Payal , Schluep Thomas , Kanner Steven B. , Hamilton James , Brugarolas James
Published: April 2023

Figure S4
Figure S3 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
Authors: Ma Yuanqing , Joyce Allison , Brandenburg Olivia , Saatchi Faeze , Stevens Christina , Toffessi Tcheuyap Vanina , Christie Alana , Do Quyen N. , Fatunde Oluwatomilade , Macchiaroli Alyssa , Wong So C. , Woolford Layton , Yousuf Qurratulain , Miyata Jeffrey , Carrillo Deyssy , Onabolu Oreoluwa , McKenzie Tiffani , Mishra Akhilesh , Hardy Tanner , He Wei , Li Daniel , Ivanishev Alexander , Zhang Qing , Pedrosa Ivan , Kapur Payal , Schluep Thomas , Kanner Steven B. , Hamilton James , Brugarolas James
Published: April 2023

Figure S3